PolyPid (PYPD) Property, Plant & Equipment (Net) Growth (3y) (2022 - 2026)
PolyPid (PYPD) Property, Plant & Equipment (Net) Growth (3y) (2022 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PP&E (Net) Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 14.05% |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 11.65% |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | 411.50% |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | -3.34% |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 16.78% |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 1.66% |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 109.44% |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 19.96% |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | - |
| 10 | PolyPid | 113.86 Mn | 107.09 Mn | - | -18.52% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -18.52% |
| Mar 31, 2026 | -18.33% |
| Dec 31, 2025 | -18.02% |
| Sep 30, 2025 | -17.07% |
| Jun 30, 2025 | -16.54% |
| Mar 31, 2025 | -15.15% |
| Dec 31, 2024 | -11.49% |
| Sep 30, 2024 | 3.91% |
| Jun 30, 2024 | 5.92% |
| Mar 31, 2024 | 6.14% |
| Dec 31, 2023 | 8.97% |
| Sep 30, 2023 | 9.32% |
| Jun 30, 2023 | 11.03% |
| Dec 31, 2022 | 14.74% |